TGFB1 and systemic sclerosis: The present study elucidates a new aspect of the pathogenic role of TGF-β in SSc by showing upregulation of IL-13 synthesis in response to TGF-β in the peripheral CD4+ and CD8+ T cells of patients with SSc, whereas IL-13 expression was downregulated by TGF-β in healthy donors.